Topics

Tetravalent dengue vaccine shows promise in children, teens

04:44 EST 8 Nov 2019 | SmartBrief

Researchers found that Takeda's tetravalent dengue vaccine candidate TAK-003 yielded 80.2% efficacy in healthy youths ages 4  -More

Original Article: Tetravalent dengue vaccine shows promise in children, teens

NEXT ARTICLE

More From BioPortfolio on "Tetravalent dengue vaccine shows promise in children, teens"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...